Atlas Trials

Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT03986073 · UNKNOWN

Trial details

NCT number
NCT03986073
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2020-01-01
Primary completion
2020-06-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.